首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1404806

兽医肿瘤市场市场规模、份额、趋势分析报告：按治疗、按动物类型、按癌症类型、按地区、细分市场预测，2024-2030 年

Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Radiotherapy, Surgery), By Animal Type (Canine, Feline), By Cancer Type, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2023年11月29日 | 出版商:

Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

兽医肿瘤学市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球兽医肿瘤市场规模预计将达到5.779亿美元。

预计2024年至2030年复合年增长率为11.29%。宠物癌症盛行率的增加和对兽医诊断的需求预计将在预测期内推动市场发展。

全球采用犬癌症登记处来估计癌症发生率也是市场成长的驱动因素。根据2019年2月《兽医科学前沿》报道，瑞士犬癌症登记处（SCCR）被用作资料来源并进行彙编，以供未来犬类和人类癌症的比较研究。该资料库进一步有助于减少人群中恶性的发生，从而促进市场成长。

进行兽医肿瘤学研究的研究人员正在进一步推动兽医肿瘤学市场的成长。例如，2017 年 8 月，伊利诺大学进行了一项研究，旨在更准确地检测狗的头颈部肿瘤转移（癌症在体内的扩散）。此外，市场参与者也关注新产品创新和策略联盟。例如，Oasmia Pharmaceutical AB 的子公司 AdvaVet 于 2018 年开发了基于奈米颗粒配方的 XR17 技术，该技术使单一活性药物成分 (API) 或多种 API 水溶性。它是联合治疗，也是宠物动物许多癌症疾病的标准治疗方法。

兽医肿瘤学市场报告亮点

伴同性动物中癌症盛行率的不断上升、评估宠物癌症治疗的安全性和有效性的多项临床试验研究以及兽医癌症治疗的技术进步正在推动市场的成长，预计将创造机会。
化疗，无论是单独治疗还是与其他治疗方法相结合，在未来几年中将占据最大的收益占有率，因为它越来越多地用于宠物癌症治疗。
2023 年，狗的收益占比最大，狗的数量不断增长，而且与猫相比，狗的癌症患病率更高。
由于其在伴同性动物中的高死亡率，淋巴瘤在 2023 年的其他癌症类型中占据了市场主导地位。根据 2018 年兽医和比较肿瘤学，胃肠道 (GI) 淋巴瘤是犬科动物中最常见的肿瘤。
由于有利的政府政策、公司推出的新产品以及对兽医肿瘤治疗的巨额投资，截至 2023 年，北美占据主导市场份额。
亚太地区正在经历动物健康和支出的增加、患倡议的宠物数量不断增加、政府对动物安全的关注以及遏制宠物癌症病例的多项倡议，预计将显示出良好的增长。
主要企业包括勃林格殷格翰 (Boehringer Ingelheim)、PetCure Oncology、Elanco、Accuray Incorporated、瓦里安医疗系统 (Varian Medical Systems)、硕腾 (Zoetis)、Karyopharm Therapeutics, Inc.、One Health 和 Regeneus Ltd。

市场体系展望
- 母市场展望
- 附随市场前景
2023 年技术普及与成长前景图
从使用者观点分析
- 市场影响力分析
- 主要最终用户名单
法律规范
- 监管状况
- 标准和合规性
技术时间轴分析
兽医肿瘤学市场动态
- 市场驱动因素分析
- 市场抑制因素分析
产业分析-波特五力分析
- 供应商议价能力：中等
- 买方议价能力：低至中等
- 替代品的威胁：中等
- 新进入者的威胁：高
- 竞争公司之间的敌意：高
美国兽医肿瘤学 - 按因素进行 SWOT 分析（政治和法律、经济、社会和技术）
- 政治和法律形势
- 经济形势
- 社会形势
- 技术形势
新型冠状病毒影响分析

第四章兽医肿瘤学市场：治疗估计与趋势分析

2023 年和 2030 年治疗市场占有率分析
治疗仪表板
外科手术
放射线治疗
化疗
免疫疗法
其他的

第五章兽医肿瘤学市场：动物类型估计与趋势分析

2023 年和 2030 年动物类型市场占有率分析
动物型仪表板
犬类
猫科动物
马

第六章兽医肿瘤学市场：癌症类型估计与趋势分析

2020 年和 2028 年癌症类型市场占有率分析
癌症类型仪表板
淋巴瘤
皮肤癌
肉瘤
其他的

第七章兽医肿瘤学市场：按产品、动物类型和最终用途的区域估计和趋势分析

2023 年和 2030 年按地区分類的兽医肿瘤市场占有率
北美洲
- 北美兽医肿瘤学市场估计与预测，2018-2030
- 美国
- 加拿大
欧洲
- 2018-2030 年欧洲兽医肿瘤市场估计与预测
- 德国
- 英国
- 法国
- 义大利
- 西班牙
亚太地区
- 2018-2030 年亚太地区兽医肿瘤市场估计与预测
- 中国
- 日本
- 印度
拉丁美洲
- 拉丁美洲兽医肿瘤学市场估计与预测，2018-2030 年
- 巴西
- 墨西哥
中东和非洲
- MEA 兽医肿瘤学市场估计和预测，2018-2030 年
- 南非

第八章兽医肿瘤学市场：竞争形势

市场参与分类
Major Deals &Strategic Alliances Analysis
公司市场分析
Boehringer Ingelheim International GmbH
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Elanco
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Zoetis
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
PetCure Oncology
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Accuray Incorporated
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Varian Medical Systems, Inc.
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Nippon Zenyaku Kogyo Co. Ltd.（ZENOAQ）
- 公司简介
- 产品基准评效
- 策略倡议
Morphogenesis
- 公司简介
- 产品基准评效
- 策略倡议
Karyopharm
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
Regeneus Ltd.
- 公司简介
- 财务绩效
- 产品基准评效
- 策略倡议
OHC（One Health Company）
- 公司简介
- 产品基准评效
- 策略倡议

简介目录图表

Product Code: GVR-4-68038-182-5

Veterinary Oncology Market Growth & Trends:

The global veterinary oncology market size is expected to reach USD 577.9 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.29% from 2024 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

Veterinary Oncology Market Report Highlights:

Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
Canine segment held the largest revenue in 2023, increasing population of dogs and high prevalence of cancer in dogs as compared to cats.
Lymphoma dominated the market among other cancer types in 2023, due to the disease's high mortality rate in companion animals. According to the Veterinary and Comparative Oncology in 2018, Gastrointestinal (GI) Lymphoma is the most common neoplasm that contracts dog population.
North America held the dominant share of as of 2023, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.
Some of the key companies are Boehringer Ingelheim, PetCure Oncology, Elanco, Accuray Incorporated, Varian Medical Systems, Zoetis, Karyopharm Therapeutics, Inc. One Health and Regeneus Ltd.

Chapter 1 Research Methodology & Scope

1.1 Market Segmentation & Scope
- 1.1.1 Segment Scope
- 1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
- 1.6.1 Target Population & Patient Stratification (Top-down estimation): mODEL 1
- 1.6.2 Assumptions/Key Considerations
- 1.6.3 Commodity Flow Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Abbreviations
1.9 Report Objectives

Chapter 2 Executive Summary

2.1 Market Outlook, 2023
2.2 Segment Outlook
2.3 Competitive Outlook

Chapter 3 Veterinary Oncology Market Variables Trends & Scope

3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping by Technology, 2023
3.3 User Perspective Analysis
- 3.3.1 Market Influencer Analysis
- 3.3.2 List of Key End Users
3.4 Regulatory Framework
- 3.4.1 Regulatory Landscape
- 3.4.2 Standards & compliances
3.5 Technology Timeline Analysis
3.6 Veterinary Oncology Market Dynamics
- 3.6.1 Market Driver Analysis
  - 3.6.1.1 Increasing prevalence and incidence of cancer in pets
  - 3.6.1.2 Growing Research and investments in pet cancer therapy
  - 3.6.1.3 Rising focus on animal safety
  - 3.6.1.4 Increasing adoption of pet insurance
  - 3.6.1.5 Technological advancements in pet cancer treatment
- 3.6.2 Market Restraint Analysis
  - 3.6.2.1 High cost of pet cancer treatments
  - 3.6.2.2 Lack of awareness among pet owners about pet diseases
  - 3.6.2.3 Adverse effects of drugs used for pet cancer treatment
3.7 Industry Analysis - Porter's
- 3.7.1 Bargaining Power of Suppliers: Moderate
- 3.7.2 Bargaining Power of Buyers: Low to Moderate
- 3.7.3 Threat of Substitutes: Moderate
- 3.7.4 Threat of New Entrants: High
- 3.7.5 Competitive Rivalry: High
3.8 U.S. Veterinary Oncology - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
- 3.8.1 Political and Legal Landscape
- 3.8.2 Economic Landscape
- 3.8.3 Social Landscape
- 3.8.4 Technology Landscape
3.9 Covid Impact Analysis

Chapter 4 Veterinary Oncology Market: Therapy Estimates & Trend Analysis

4.1 Therapy Market Share Analysis, 2023 & 2030
4.2 Therapy Dashboard
4.3 Surgery
- 4.3.1 Surgery market estimates and forecasts, 2018 - 2030 (USD Million)
4.4 Radiotherapy
- 4.4.1 Radiotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.5 Chemotherapy
- 4.5.1 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.6 Immunotherapy
- 4.6.1 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.7 Others
- 4.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Veterinary Oncology Market: Animal Type Estimates & Trend Analysis

5.1 Animal Type Market Share Analysis, 2023 & 2030
5.2 Animal Type Dashboard
5.3 Canine
- 5.3.1 Canine market estimates and forecasts, 2018 - 2030 (USD million)
5.4 Feline
- 5.4.1 Feline market estimates and forecasts, 2018 - 2030 (USD million)
5.5 Equine
- 5.5.1 Equine market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6 Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

6.1 Cancer Type Market Share Analysis, 2020 & 2028
6.2 Cancer Type Dashboard
6.3 Lymphoma
- 6.3.1 Lymphoma market estimates and forecasts, 2018 - 2030 (USD Million)
6.4 Skin Cancers
- 6.4.1 Skin Cancers market estimates and forecasts, 2018 - 2030 (USD Million)
6.5 Sarcomas
- 6.5.1 Sarcomas market estimates and forecasts, 2018 - 2030 (USD Million)
6.6 Others
- 6.6.1 Other market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Veterinary Oncology Market: Regional Estimates & Trend Analysis by Product, Animal Type, and End-Use

7.1 Veterinary Oncology Market Shares By Region, 2023 & 2030
7.2 North America
- 7.2.1 North America Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.2 U.S.
  - 7.2.2.1 U.S. Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.3 Canada
  - 7.2.3.1 Canada Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.3 Europe
- 7.3.1 Europe Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.2 Germany
  - 7.3.2.1 Germany Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.3 UK
  - 7.3.3.1 UK Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.4 France
  - 7.3.4.1 France Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.5 Italy
  - 7.3.5.1 Italy Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.6 Spain
  - 7.3.6.1 Spain Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
- 7.4.1 Asia Pacific Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2 China
  - 7.4.2.1 China Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3 Japan
  - 7.4.3.1 Japan Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4 India
  - 7.4.4.1 India Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
- 7.5.1 Latin America Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2 Brazil
  - 7.5.2.1 Brazil Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Mexico
  - 7.5.3.1 Mexico Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
- 7.6.1 MEA Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2 South Africa
  - 7.6.2.1 SOuth Africa Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Veterinary Oncology Market: Competitive Landscape

8.1 Market Participation Categorization
8.2 Major Deals & Strategic Alliances Analysis
8.3 Company market position analysis
8.4 Boehringer Ingelheim International GmbH
- 8.4.1 Company overview
- 8.4.2 Financial performance
- 8.4.3 Product benchmarking
- 8.4.4 Strategic initiatives
8.5 Elanco
- 8.5.1 Company overview
- 8.5.2 Financial performance
- 8.5.3 Product benchmarking
- 8.5.4 Strategic initiatives
8.6 Zoetis
- 8.6.1 Company overview
- 8.6.2 Financial performance
- 8.6.3 Product benchmarking
- 8.6.4 Strategic initiatives
8.7 PetCure Oncology
- 8.7.1 Company overview
- 8.7.2 Financial performance
- 8.7.3 Product benchmarking
- 8.7.4 Strategic initiatives
8.8 Accuray Incorporated
- 8.8.1 Company overview
- 8.8.2 Financial performance
- 8.8.3 Product benchmarking
- 8.8.4 Strategic initiatives
8.9 Varian Medical Systems, Inc.
- 8.9.1 Company overview
- 8.9.2 Financial performance
- 8.9.3 Product benchmarking
- 8.9.4 Strategic initiatives
8.10 Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
- 8.10.1 Company overview
- 8.10.2 Product benchmarking
- 8.10.3 Strategic initiatives
8.11 Morphogenesis
- 8.11.1 Company overview
- 8.11.2 Product benchmarking
- 8.11.3 Strategic initiatives
8.12 Karyopharm
- 8.12.1 Company overview
- 8.12.2 Financial performance
- 8.12.3 Product benchmarking
- 8.12.4 Strategic initiatives
8.13 Regeneus Ltd.
- 8.13.1 Company overview
- 8.13.2 Financial performance
- 8.13.3 Product benchmarking
- 8.13.4 Strategic Initiatives
8.14 OHC (One Health Company)
- 8.14.1 Company overview
- 8.14.2 Product benchmarking
- 8.14.3 Strategic Initiatives

简介目录图表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 List of veterinary oncology service providers
Table 4 North America veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 5 North America veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 6 North America veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 7 U.S. veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 8 U.S. veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 9 U.S. veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 10 Canada veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 11 Canada veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 12 Canada veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 13 Europe veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 14 Europe veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 15 Europe veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 16 UK veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 17 UK veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 18 UK veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 19 Germany veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 20 Germany veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 21 Germany veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 22 France veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 23 France veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 24 France veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 25 Italy veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 26 Italy veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 27 Italy veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Spain veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 29 Spain veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 30 Spain veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 31 Asia Pacific veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 32 Asia Pacific veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 33 Asia Pacific veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 34 China veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 35 China veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 36 China veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 37 Japan veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 38 Japan veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 39 Japan veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 40 India veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 41 India veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 42 India veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 43 Latin America veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 44 Latin America veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 45 Latin America veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 46 Brazil veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 47 Brazil veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 48 Brazil veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 49 Mexico veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 50 Mexico veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 51 Mexico veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 52 MEA veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 53 MEA veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 54 MEA veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 55 South Africa veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 56 South Africa oncology market, by animal type, 2018 - 2030 (USD Million)
Table 57 South Africa oncology market, by cancer type, 2018 - 2030 (USD Million)